- Home
- NAII vs RNXT Comparison
NAII vs RNXT Comparison
Compare NAII & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- RNXT
- Stock Information
- Founded
- NAII 1980
- RNXT 2012
- Country
- NAII United States
- RNXT United States
- Employees
- NAII N/A
- RNXT N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- NAII Health Care
- RNXT Health Care
- Exchange
- NAII Nasdaq
- RNXT Nasdaq
- Market Cap
- NAII 28.0M
- RNXT 21.6M
- IPO Year
- NAII 1987
- RNXT 2021
- Fundamental
- Price
- NAII $4.65
- RNXT $1.01
- Analyst Decision
- NAII
- RNXT Strong Buy
- Analyst Count
- NAII 0
- RNXT 3
- Target Price
- NAII N/A
- RNXT $6.13
- AVG Volume (30 Days)
- NAII 17.8K
- RNXT 20.8K
- Earning Date
- NAII 11-11-2024
- RNXT 11-12-2024
- Dividend Yield
- NAII N/A
- RNXT N/A
- EPS Growth
- NAII N/A
- RNXT N/A
- EPS
- NAII N/A
- RNXT N/A
- Revenue
- NAII $113,796,000.00
- RNXT N/A
- Revenue This Year
- NAII N/A
- RNXT N/A
- Revenue Next Year
- NAII N/A
- RNXT N/A
- P/E Ratio
- NAII N/A
- RNXT N/A
- Revenue Growth
- NAII N/A
- RNXT N/A
- 52 Week Low
- NAII $4.13
- RNXT $0.53
- 52 Week High
- NAII $7.37
- RNXT $2.35
- Technical
- Relative Strength Index (RSI)
- NAII 41.72
- RNXT 52.74
- Support Level
- NAII $4.31
- RNXT $0.77
- Resistance Level
- NAII $4.95
- RNXT $1.03
- Average True Range (ATR)
- NAII 0.24
- RNXT 0.05
- MACD
- NAII 0.05
- RNXT 0.01
- Stochastic Oscillator
- NAII 46.58
- RNXT 95.49
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.